Deferred Tax Assets, Valuation Allowance of Cidara Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cidara Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Cidara Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $120,898,000, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $120,898,000 +$37,812,000 +46% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $83,086,000 +$6,373,000 +8.3% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $76,713,000 -$19,684,000 -20% 31 Dec 2022 10-K 22 Apr 2024 2023 FY
Q4 2021 $96,397,000 +$11,789,000 +14% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $84,608,000 +$15,913,000 +23% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q4 2019 $68,695,000 +$13,691,000 +25% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $55,004,000 +$16,421,000 +43% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q4 2017 $38,583,000 +$5,132,000 +15% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $33,451,000 +$14,997,000 +81% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $18,454,000 +$13,123,000 +246% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $5,331,000 +$4,849,000 +1006% 31 Dec 2014 10-K 18 Mar 2016 2015 FY
Q4 2013 $482,000 31 Dec 2013 10-K 18 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.